4//SEC Filing
Daniels Kevin 4
Accession 0000950170-24-001245
CIK 0001958086other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:47 PM ET
Size
8.2 KB
Accession
0000950170-24-001245
Insider Transaction Report
Form 4
Daniels Kevin
CAO & Treasurer
Transactions
- Tax Payment
Common Stock
2023-12-31$17.66/sh−2,769$48,901→ 13,180 total - Exercise/Conversion
Performance Shares
2023-12-31−7,200→ 0 totalExercise: $0.00→ Common Stock (7,200 underlying) - Exercise/Conversion
Common Stock
2023-12-31+7,200→ 15,949 total
Footnotes (1)
- [F1]These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on Decmeber 31, 2023 at the conclusion of the performance period.
Documents
Issuer
Core Laboratories Inc. /DE/
CIK 0001958086
Entity typeother
Related Parties
1- filerCIK 0001740507
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:47 PM ET
- Size
- 8.2 KB